Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Panel To Weigh Safety, Tolerability Issues For One New, Two Approved Cancer Drugs
Jul 21 2022
•
By
Sue Sutter
FDA has issued safety alerts about Pepaxto and Copiktra, two of the three drugs ODAC will discuss at a September meeting. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers